These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21232565)

  • 1. The challenges and promises of blood engineered from human pluripotent stem cells.
    Dravid GG; Crooks GM
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):331-41. PubMed ID: 21232565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
    Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
    Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?
    Ronaghi M; Erceg S; Moreno-Manzano V; Stojkovic M
    Stem Cells; 2010 Jan; 28(1):93-9. PubMed ID: 19904738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis.
    Hong SH; Lee JH; Lee JB; Ji J; Bhatia M
    J Cell Sci; 2011 May; 124(Pt 9):1445-52. PubMed ID: 21486943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects and challenges of induced pluripotent stem cells as a source of hematopoietic stem cells.
    van Bekkum DW; Mikkers HM
    Ann N Y Acad Sci; 2012 Aug; 1266():179-88. PubMed ID: 22901269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney repair using stem cells: myth or reality as a therapeutic option?
    Iwatani H; Imai E
    J Nephrol; 2010; 23(2):143-6. PubMed ID: 20175054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells.
    Godfrey KJ; Mathew B; Bulman JC; Shah O; Clement S; Gallicano GI
    Diabet Med; 2012 Jan; 29(1):14-23. PubMed ID: 21883442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise review: stem cells for the treatment of cerebellar-related disorders.
    Erceg S; Moreno-Manzano V; Garita-Hernandez M; Stojkovic M; Bhattacharya SS
    Stem Cells; 2011 Apr; 29(4):564-9. PubMed ID: 21319272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
    Puri MC; Nagy A
    Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Utilization of the ES/iPS cell technology for hematopoietic stem cell transplantation].
    Otsu M; Nakauchi H
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():146-50. PubMed ID: 23133943
    [No Abstract]   [Full Text] [Related]  

  • 11. Differentiation of embryonic stem cells towards hematopoietic cells: progress and pitfalls.
    Tian X; Kaufman DS
    Curr Opin Hematol; 2008 Jul; 15(4):312-8. PubMed ID: 18536568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models.
    Kong CW; Akar FG; Li RA
    Thromb Haemost; 2010 Jul; 104(1):30-8. PubMed ID: 20539906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human ES and iPS cells as cell sources for the treatment of Parkinson's disease: current state and problems.
    Hwang DY; Kim DS; Kim DW
    J Cell Biochem; 2010 Feb; 109(2):292-301. PubMed ID: 20014069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An introduction to induced pluripotent stem cells.
    Hanley J; Rastegarlari G; Nathwani AC
    Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of induced pluripotent stem cells.
    Okita K; Nagata N; Yamanaka S
    Circ Res; 2011 Sep; 109(7):720-1. PubMed ID: 21921270
    [No Abstract]   [Full Text] [Related]  

  • 16. [An overview of pluripotent stem cell lines].
    Kieffer E; Kuntz S; Viville S
    Med Sci (Paris); 2010 Oct; 26(10):848-54. PubMed ID: 20929676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regenerative cells for transplantation in hepatic failure.
    Ishikawa T; Banas A; Teratani T; Iwaguro H; Ochiya T
    Cell Transplant; 2012; 21(2-3):387-99. PubMed ID: 22793046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene flaw found in induced stem cells.
    Dolgin E
    Nature; 2010 Apr; 464(7289):663. PubMed ID: 20360708
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell processing engineering for ex-vivo expansion of hematopoietic cells.
    Takagi M
    J Biosci Bioeng; 2005 Mar; 99(3):189-96. PubMed ID: 16233777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.